Home/Exeliom Biosciences/Philippe Langella
PL

Philippe Langella

Scientific Co-founder, Research Director

Exeliom Biosciences

Exeliom Biosciences Pipeline

DrugIndicationPhase
EXL01Cancer (combination with Immune Checkpoint Inhibitors)Phase 2